A Phase I Study of OCV-501 in Acute Myeloid Leukemia Patients
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability of OCV-501 in patients with
acute myeloid leukemia (AML) who achieved complete remission after induction regimen and who
completed a standard consolidation therapy.